News about Global Pharma

Momentum Biotechnologies Completes Acquisition of OmicScouts

With this transaction, Momentum gains access to a broad portfolio of well-validated proteomic assays that enhance and extend their existing service offerings, enabling clients to seamlessly progress from high-throughput screening into cell-based assays, as well as to discover new targets and biomarkers.

Global Pharma | 11/03/2025 | By Aishwarya |  182

Aragen Strengthens Leadership with Two Key Appointments

Jayadeva joins as the Vice President and Head of Chemical Development Solutions (CDS), one of the largest and critical businesses of Aragen.

Global Pharma | 11/03/2025 | By Aishwarya |  282

Govt of India Invites Proposals for Funding Under PRIP Scheme

The DoP is seeking participation from proprietary firms, partnership firms, limited liability partnerships, startups, and companies or groups of companies registered in India.

Global Pharma | 11/03/2025 | By Aishwarya |  435

Isotopia Launches Isoprotrace in Germany

Isotopia has officially launched Isoprotrace® in Germany. DSD Pharma, a trusted pharmaceutical distributor in Germany, will serve as the exclusive partner for the distribution of Isoprotrace® throughout the country, ensuring efficient, consistent delivery to hospitals, clinics, and diagnostic centres across Germany.

Global Pharma | 10/03/2025 | By Manvi |  131

Indoco's CRO AnaCipher Completed US FDA Inspection

Indoco Remedies Ltd. has announced that its Clinical Research Organisation, AnaCipher, located at Hyderabad, has completed its 5-day comprehensive USFDA inspection. The on-site inspection was conducted from March 3-7, 2025, by investigators from Bioresearch Monitoring Program (BIMO) and Office of Study Integrity & Surveillance (OSIS) of US FDA.

Global Pharma | 10/03/2025 | By Manvi |  305

Biocon Biologics and Civica to Expand Insulin Aspart Access in US

Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials. No technology transfer is involved in the agreement.

Global Pharma | 10/03/2025 | By Aishwarya |  408

Sun Pharma to Acquire Checkpoint Therapeutics

Checkpoint has received approval from the US Food & Drug Administration (FDA) for UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation.

Global Pharma | 10/03/2025 | By Aishwarya |  212

Moleculin Announces Additional Annamycin Patent Allowances

Moleculin Biotech, Inc., a late-stage pharmaceutical company focused on developing innovative treatments for hard-to-treat cancers and viruses, has received a Notice of Intent to Grant for its European patent application covering the formulation of liposomal Annamycin.

Global Pharma | 07/03/2025 | By Manvi |  183

Zydus Secures Final Approval from USFDA for Dasatinib Tablets in Multiple Doses

Zydus Lifesciences has received USFDA approval to manufacture Dasatinib tablets 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg for treating Philadelphia chromosome-positive leukaemias. These tablets will be produced in the company’s Ahmedabad facility.

Global Pharma | 07/03/2025 | By Manvi |  410

Enzene Bags EU GMP Certification for its Facilities in India

Enzene is a fully integrated, end-to-end CDMO with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA).

Global Pharma | 07/03/2025 | By Aishwarya |  469